Atlas Trials

Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma

Clinical trial NCT01290120 · COMPLETED

Trial details

NCT number
NCT01290120
Sponsor
Northern Italy Leukemia Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Burkitt LymphomaB-ALL
Start date
2002-11-01
Primary completion
2014-06-01
Enrollment
182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.